Christopher Peetz - Jul 3, 2023 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
President and CEO, Director
Signature
/s/ Judit Ryvkin, Attorney-in-Fact
Stock symbol
MIRM
Transactions as of
Jul 3, 2023
Transactions value $
-$141,005
Form type
4
Date filed
7/5/2023, 07:30 PM
Previous filing
May 19, 2023
Next filing
Jan 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Sale -$141K -5.5K -4.55% $25.65 115K Jul 3, 2023 Direct F1
holding MIRM Common Stock 202K Jul 3, 2023 By The Peetz Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.